BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND RPL22, EAP, 6146 AND Treatment
6 results:

  • 1. Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
    de Moura A; Vuagnat P; Renouf B; Pierga JY; Loirat D; Vaflard P; Lafayolle de la Bruyère C; Chaumard-Billotey N; Hajjaji N; Ladoire S; Dabakuyo S; Patsouris A; Frenel JS; Nicolai V; Alexandre M; Dohollou N; Grenier J; Bourien H; Bidard FC
    Sci Rep; 2023 Aug; 13(1):13427. PubMed ID: 37596388
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR
    Brufsky A; Mitra D; Davis KL; Nagar SP; McRoy L; Cotter MJ; Stearns V
    Clin Breast Cancer; 2019 Oct; 19(5):317-325.e4. PubMed ID: 31104984
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expanded-Access Study of Palbociclib in Combination With Letrozole for treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced breast cancer.
    Stearns V; Brufsky AM; Verma S; Cotter MJ; Lu DR; Dequen F; Joy AA
    Clin Breast Cancer; 2018 Dec; 18(6):e1239-e1245. PubMed ID: 30172722
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus.
    Schneider D; Liaw L; Daniel C; Athanasopoulos AN; Herrmann M; Preissner KT; Nawroth PP; Chavakis T
    Biochem Biophys Res Commun; 2007 May; 357(1):282-8. PubMed ID: 17418809
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Four cases of advanced adenocarcinoma showing marked response to eap (etoposide, ADM, CDDP) treatment].
    Iba T; Yagi Y; Kidokoro A; Fukunaga M; Fukunaga T; Mishima S
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2383-5. PubMed ID: 8259856
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Remarkable effect of the combination therapy of etoposide, epiadriamycin, and CDDP (eap) in the treatment of metachronous lung metastases of breast cancer--a case report].
    Kawabe T; Honda I; Kawakami Y; Fujita M; Watanabe K; Ryu M; Watanabe S; Yoshida M; Matsushita K
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2467-9. PubMed ID: 1659328
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.